RESULTS
INTRODUCTION

CONCLUSIONS
This study has demonstrated that the AAV community is active on social media in European countries.
There is significant variation in the volume, originator, platform and content between countries. In some countries eg UK, patients are very active on specific social media platforms sharing their experiences and looking to support each other.
The detailed analysis has demonstrated the areas of particular concern for patients and discussed most online; Unmet need and challenges -time to diagnosis, impact on their life and need for more information Symptoms -local specific symptoms to the patient Treatments -the impact of glucorticoids Attention should be paid to patient experience and opinion through social media discussions when considering new therapy options in AAV.
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